![]() Versantis Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications. | ![]() Metabolomic Technologies Metabolomic Technologies is a company that develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
| |||
Founding Date | Founding Date 2011 | Founding Date 1993 | Founding Date 2015 | Founding Date 2010 |
Type | Type Subsidiary | Type Public | Type Private | Type Private |
Tags | ||||
Locations | Locations San Jose, US HQ | Locations Holon, IL HQ South San Francisco, US | Locations Zürich, CH HQ | Locations Edmonton, CA HQ Edmonton, CA |
Employees | Employees 75 | Employees 74 | Employees 2 | Employees 3 |
Funding | ||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 16.1m (over 6 years ago) | Latest funding round $ 4.2m (over 6 years ago) |
Total funding raised | Total funding raised $ 12.5m | Total funding raised N/A | Total funding raised $ 20.7m | Total funding raised $ 4.2m |

Versantis is a developer of liver disease therapeutics and diagnostics intended to provide the first drug capture platform for the treatment of life-threatening intoxications.
View company
Metabolomic Technologies is a company that develops patented, metabolomic-based, diagnostic tests to detect adenomatous polyps and colorectal cancer (CRC).
View company